A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes (Q34628386)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes |
scientific article |
Statements
1 reference
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes (English)
1 reference
Werner Poewe
1 reference
Eduardo Tolosa
1 reference
Olivier Rascol
1 reference
Joseph Jankovic
1 reference
Robert Hauser
1 reference
C Warren Olanow
1 reference
J William Langston
1 reference
Eldad Melamed
1 reference
Cheryl J Fitzer-Attas
1 reference
Eli Eyal
1 reference
Yoni M Weiss
1 reference
1 reference
Identifiers
1 reference